No headlines found.
eXoZymes Awarded $2 Million NIH Grant to Advance Cannabinoid Analogs for Drug Discovery
ACCESS Newswire (Wed, 24-Jun 4:10 PM ET)
eXoZymes Inc. Announces Closing of $6 Million Public Offering
ACCESS Newswire (Wed, 17-Jun 4:10 PM ET)
eXoZymes Inc. Announces Pricing of Public Offering of Common Stock and Warrants
ACCESS Newswire (Mon, 8-Jun 9:00 AM ET)
eXoZymes Announces Graduation from Shell GameChanger(TM) Accelerator Powered by NLR (GCxN) Program
ACCESS Newswire (Thu, 7-May 9:05 AM ET)
EXoZymes Inc is focused on using a biomanufacturing platform to create valuable biochemicals, including Active Pharmaceutical Ingredients or APIs, biofuels, food flavors, and cosmetics, offering a sustainable alternative to traditional chemical production methods. The company believes its platform will enable scalable production of chemical molecules found in nature in a process that is alternative to and more environmentally friendly and sustainable than the typical methods used today, such as chemical synthesis, natural extraction, and synthetic biology.
Exozymes trades on the NASDAQ stock market under the symbol EXOZ.
As of July 10, 2026, EXOZ stock price declined to $6.97 with 7,046 million shares trading.
EXOZ has a market cap of $64.69 million. This is considered a Micro Cap stock.
The top ETF exchange traded funds that EXOZ belongs to (by Net Assets): VXF, VTI, IWC.
EXOZ has underperformed the market in the last year with a price return of -30.4% while the SPY ETF gained +21.8%. EXOZ has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -40.4% and -13.2%, respectively, while the SPY returned +11.4% and +3.6%, respectively.
EXOZ support price is $6.42 and resistance is $7.74 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that EXOZ shares will trade within this expected range on the day.